Drug · DIN 00778338
AXID
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 26, 2013; first marketed December 31, 1988.
- Drug Identification Number (DIN)
- 00778338
- Company (DIN owner)
- Pendopharm Division Of Pharmascience IncMontreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Nizatidine A02BA04
- Class
- Human
- Record last updated
- June 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NIZATIDINE | 150 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 10, 2012: NOC 13024New Drug Submission (NDS) · Manufacturer name change
- October 5, 2009: NOC 10638New Drug Submission (NDS) · Manufacturer name change
- August 7, 2002: NOC 710New Drug Submission (NDS) · Manufacturer name change
- February 4, 2002: NOC 720New Drug Submission (NDS) · Manufacturer name change
Other DINs named AXID
- DIN 00778346 · Dormant